FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

422988009: biskalcitrate de bismuth (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
193221000077119 biskalcitrate de bismuth fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
2640344010 Bismuth biskalcitrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2644399011 Bismuth biskalcitrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
469911000077119 biskalcitrate de bismuth (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
biskalcitrate de bismuth est un(e) (attribut) composé de bismuth true Inferred relationship Some
biskalcitrate de bismuth est un(e) (attribut) Antacid (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only bismuth biskalcitrate (medicinal product) a pour principe actif (attribut) True biskalcitrate de bismuth Inferred relationship Some 1
Product containing only bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) a pour principe actif (attribut) True biskalcitrate de bismuth Inferred relationship Some 3
Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form a pour principe actif (attribut) True biskalcitrate de bismuth Inferred relationship Some 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient False biskalcitrate de bismuth Inferred relationship Some 3
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule Has precise active ingredient True biskalcitrate de bismuth Inferred relationship Some 3
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule Has basis of strength substance (attribute) True biskalcitrate de bismuth Inferred relationship Some 3
Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) a pour principe actif (attribut) True biskalcitrate de bismuth Inferred relationship Some 3
Product containing bismuth biskalcitrate (medicinal product) a pour principe actif (attribut) True biskalcitrate de bismuth Inferred relationship Some 1
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) a pour principe actif (attribut) False biskalcitrate de bismuth Inferred relationship Some
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) False biskalcitrate de bismuth Inferred relationship Some 2
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) a pour principe actif (attribut) False biskalcitrate de bismuth Inferred relationship Some 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) False biskalcitrate de bismuth Inferred relationship Some 3
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient False biskalcitrate de bismuth Inferred relationship Some 2
Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) a pour principe actif (attribut) True biskalcitrate de bismuth Inferred relationship Some 3

This concept is not in any reference sets

Back to Start